Impact of Artificial Intelligence-Supported Educational Intervention on Mothers' Fever Management
NCT ID: NCT07086547
Last Updated: 2025-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
80 participants
INTERVENTIONAL
2025-11-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will be conducted as a pretest-posttest experimental design including 80 mothers of children who visit the Pediatric Emergency Clinic at Kayseri City Hospital. Participants will be assigned to either an intervention group receiving AI-supported fever management education or a control group receiving standard care.
Data will be collected using validated scales to assess parental fever management knowledge and anxiety levels before and after the intervention. The educational material was developed using ChatGPT 4.0, a large language model AI platform, and reviewed by pediatric experts.
The results of this study may improve fever management education and reduce anxiety among mothers, potentially leading to better health outcomes for children.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Online Training to Improve Parents' Fever Management Practices
NCT07061327
Fever Education Given to Parents of Children Presenting to the Emergency Department With Fever
NCT06599853
Evaluation of the Effectiveness of the Training Given to Mothers With 0-5 Age Group Children for Fire Management
NCT06043479
The Effect of Salutogenic Model-Based Care on Mothers of Children Suffering From Febrile Illness
NCT07265401
The Evaluation of the Effectiveness of Febrile Seizure Training Given to Parents
NCT07027501
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study uses a pretest-posttest experimental design involving 80 mothers visiting the Pediatric Emergency Clinic at Kayseri City Hospital. Participants are assigned to either an intervention group receiving education developed using ChatGPT 4.0, reviewed by pediatric experts, or a control group receiving standard care.
Data collection tools include validated scales measuring fever management knowledge and anxiety levels. The intervention aims to empower mothers with better skills and reduce anxiety, potentially improving child health outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AI-Based Education Group
Mothers in this group will receive fever management education developed using an artificial intelligence language model (ChatGPT 4.0). The education includes written materials with visual content on managing fever in children and is delivered as a one-time structured session.
AI-Based Fever Management Education
This intervention consists of a fever management education program developed using ChatGPT 4.0, a large language model by OpenAI. The educational content includes seven pages and eight visuals explaining how to manage fever in children. The content was reviewed by pediatric specialists and revised accordingly. It is delivered as a one-time structured session to mothers in the intervention group.
Control Group
Mothers in this group will receive routine care and no additional fever education materials.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AI-Based Fever Management Education
This intervention consists of a fever management education program developed using ChatGPT 4.0, a large language model by OpenAI. The educational content includes seven pages and eight visuals explaining how to manage fever in children. The content was reviewed by pediatric specialists and revised accordingly. It is delivered as a one-time structured session to mothers in the intervention group.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mothers with children aged between 6 months and 5 years,
* No hearing problems,
* Agree to participate in the study,
* Presenting to the pediatric emergency department with a complaint of fever in their child,
* Child admitted to the emergency observation room for treatment,
* Able to speak and understand Turkish.
Exclusion Criteria
* Mothers whose children have had febrile seizures,
* Mothers whose children have comorbid diseases,
* Mothers whose children have symptoms requiring medical intervention other than fever.
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ISMIRA JULFAYEVA
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ISMIRA JULFAYEVA
Master's Student and nurse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erciyes University (ERÜ) Health Application and Research Center, Fevzi Mercan-Mustafa Eraslan Children's Hospital, Pediatric Emergency Unit
Kayseri, Talas, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10718356
Identifier Type: OTHER
Identifier Source: secondary_id
10718356
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.